Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study

Publisher： Karger

E-ISSN： 1664-5456|6|3|84-95

ISSN： 1664-5456

Source： Cerebrovascular Diseases Extra, Vol.6, Iss.3, 2016-10, pp. : 84-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Autopsied Case of an Apparent Pontine Branch Atheromatous Disease

By  

European Neurology, Vol. 63, Iss. 3, 2010-03 ,pp. : 184-185

Karger

Access to resources Recommend Favorite

Antiplatelet Therapy in Stroke Prevention

By  

Cerebrovascular Diseases, Vol. 15, Iss. 2, 2003-04 ,pp. : 43-48

Karger

Access to resources Recommend Favorite

Antiplatelet Cilostazol Is Effective in the Prevention of Pneumonia in Ischemic Stroke Patients in the Chronic Stage

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 57-60

Karger

Access to resources Recommend Favorite

Branch Atheromatous Disease: A Clinically Meaningful, Yet Unproven Concept

By  

Cerebrovascular Diseases, Vol. 41, Iss. 1-2, 2016-0 ,pp. : 87-95

Karger

Access to resources Recommend Favorite

Combined Antiplatelet Therapy: Still a Sweeping Combination in Cardiology

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 2, 2013-06 ,pp. : 136-167

Bentham Science Publishers

Access to resources Recommend Favorite